| Mr Mario Carlos Ponce Alvarez, MD | |
|
96 Jonathan Lucas St, Csb Suite 812, Msc 630, Charleston, SC 29425-8900 | |
| (843) 792-2123 | |
| Not Available |
| Full Name | Mr Mario Carlos Ponce Alvarez |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 17 Years |
| Location | 96 Jonathan Lucas St, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386930105 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 38137 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grady Memorial Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Morehouse Healthcare, Inc. | 6002701273 | 114 |
News Archive
Turmeric, a bright yellow spice from south Asia belonging to the ginger family, is the main ingredient in curries - and ancient wisdom suggests that it's also good for your health. Taking this wisdom to the laboratory, Tel Aviv University researchers have discovered that turmeric's active ingredient called curcumin amplifies the therapeutic activity of highly toxic anti-inflammatory drugs used to fight colon cancer when used at high doses.
24-h pH monitoring and esophageal manometry are the gold standards of methods used for diagnosing GER and esophageal motor disorders, respectively.
One of the defining characteristics of solid tumors is the development of a network of new blood vessels to nourish the rapidly reproducing malignant cells. Now, using a nanoparticle targeted to those new blood vessels, a joint academic-industrial research team, led by investigators from the Siteman Center of Cancer Nanotechnology Excellence, has developed a way to construct a three-dimensional (3-D) map of tumor-induced angiogenesis and monitor the effects of drug therapies on those new blood vessels.
A new study, released as a preprint on the bioRxiv* server, presents a new monoclonal antibody (MAb) called DZIF-10c that powerfully neutralizes SARS-CoV-2, including the current variants of concern (VOCs). With high bioavailability in the lungs and wide distribution in the body, the antibody was able to prevent SARS-CoV-2 infection in mice after intranasal administration.
Physician-assisted death was supported by a majority of California and Hawaii residents, regardless of their ethnicity, who responded to an online survey, according to a study by researchers at the Stanford University School of Medicine.
› Verified 6 days ago
| Entity Name | Morehouse Healthcare, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801832324 PECOS PAC ID: 6002701273 Enrollment ID: O20040217000570 |
News Archive
Turmeric, a bright yellow spice from south Asia belonging to the ginger family, is the main ingredient in curries - and ancient wisdom suggests that it's also good for your health. Taking this wisdom to the laboratory, Tel Aviv University researchers have discovered that turmeric's active ingredient called curcumin amplifies the therapeutic activity of highly toxic anti-inflammatory drugs used to fight colon cancer when used at high doses.
24-h pH monitoring and esophageal manometry are the gold standards of methods used for diagnosing GER and esophageal motor disorders, respectively.
One of the defining characteristics of solid tumors is the development of a network of new blood vessels to nourish the rapidly reproducing malignant cells. Now, using a nanoparticle targeted to those new blood vessels, a joint academic-industrial research team, led by investigators from the Siteman Center of Cancer Nanotechnology Excellence, has developed a way to construct a three-dimensional (3-D) map of tumor-induced angiogenesis and monitor the effects of drug therapies on those new blood vessels.
A new study, released as a preprint on the bioRxiv* server, presents a new monoclonal antibody (MAb) called DZIF-10c that powerfully neutralizes SARS-CoV-2, including the current variants of concern (VOCs). With high bioavailability in the lungs and wide distribution in the body, the antibody was able to prevent SARS-CoV-2 infection in mice after intranasal administration.
Physician-assisted death was supported by a majority of California and Hawaii residents, regardless of their ethnicity, who responded to an online survey, according to a study by researchers at the Stanford University School of Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mario Carlos Ponce Alvarez, MD 96 Jonathan Lucas St, Csb Suite 812, Msc 630, Charleston, SC 29425-8900 Ph: () - | Mr Mario Carlos Ponce Alvarez, MD 96 Jonathan Lucas St, Csb Suite 812, Msc 630, Charleston, SC 29425-8900 Ph: (843) 792-2123 |
News Archive
Turmeric, a bright yellow spice from south Asia belonging to the ginger family, is the main ingredient in curries - and ancient wisdom suggests that it's also good for your health. Taking this wisdom to the laboratory, Tel Aviv University researchers have discovered that turmeric's active ingredient called curcumin amplifies the therapeutic activity of highly toxic anti-inflammatory drugs used to fight colon cancer when used at high doses.
24-h pH monitoring and esophageal manometry are the gold standards of methods used for diagnosing GER and esophageal motor disorders, respectively.
One of the defining characteristics of solid tumors is the development of a network of new blood vessels to nourish the rapidly reproducing malignant cells. Now, using a nanoparticle targeted to those new blood vessels, a joint academic-industrial research team, led by investigators from the Siteman Center of Cancer Nanotechnology Excellence, has developed a way to construct a three-dimensional (3-D) map of tumor-induced angiogenesis and monitor the effects of drug therapies on those new blood vessels.
A new study, released as a preprint on the bioRxiv* server, presents a new monoclonal antibody (MAb) called DZIF-10c that powerfully neutralizes SARS-CoV-2, including the current variants of concern (VOCs). With high bioavailability in the lungs and wide distribution in the body, the antibody was able to prevent SARS-CoV-2 infection in mice after intranasal administration.
Physician-assisted death was supported by a majority of California and Hawaii residents, regardless of their ethnicity, who responded to an online survey, according to a study by researchers at the Stanford University School of Medicine.
› Verified 6 days ago
Dr. Jeffrey Peter Yourshaw, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425 Phone: 843-876-4807 Fax: 843-876-4809 | |
Jennifer Lee Martin, D.O. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Nikko Rowe Asuncion Tabliago, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2575 | |
Moses K Asempah, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 717-491-3745 | |
Paige Nicole Laverick, PA-C Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Amit Agrawal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Yevgeniy Gelfand, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-0111 |